Literature DB >> 17194429

[Guidelines for the management of patients with atrial fibrillation. Executive summary].

Valentín Fuster, Lars E Rydén, David S Cannom, Harry J Crijns, Anne B Curtis, Kenneth A Ellenbogen, Jonathan L Halperin, Jean-Yves Le Heuzey, G Neal Kay, James E Lowe, S Bertil Olsson, Eric N Prystowsky, Juan L Tamargo, Samuel Wann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17194429

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN： 0300-8932            Impact factor:   4.753


× No keyword cloud information.
  7 in total

Review 1.  Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

Authors:  Marco P Donadini; James D Douketis
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

2.  Anatomical analysis of the left atrial appendage using segmented, three-dimensional cardiac CT: a comparison of patients with paroxysmal and persistent forms of atrial fibrillation.

Authors:  Daniel T Walker; Julie A Humphries; Karen P Phillips
Journal:  J Interv Card Electrophysiol       Date:  2011-11-26       Impact factor: 1.900

3.  Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.

Authors:  Pamela K Mason; Douglas E Lake; John P DiMarco; John D Ferguson; J Michael Mangrum; Kenneth Bilchick; Liza P Moorman; J Randall Moorman
Journal:  Am J Med       Date:  2012-04-11       Impact factor: 4.965

4.  Areca nut chewing and risk of atrial fibrillation in Taiwanese men: a nationwide ecological study.

Authors:  Wei-Chung Tsai; Chung-Yu Chen; Hsuan-Fu Kuo; Ming-Tsang Wu; Wei-Hua Tang; Chih-Sheng Chu; Tsung-Hsien Lin; Ho-Ming Su; Po-Chao Hsu; Shih-Jie Jhuo; Ming-Yen Lin; Kun-Tai Lee; Sheng-Hsiung Sheu; Wen-Ter Lai
Journal:  Int J Med Sci       Date:  2013-04-25       Impact factor: 3.738

5.  May toxicity of amiodarone be prevented by antioxidants? A cell-culture study.

Authors:  Ahmet Baris Durukan; Beril Erdem; Elif Durukan; Handan Sevim; Tugce Karaduman; Hasan Alper Gurbuz; Aylin Gurpinar; Cem Yorgancioglu
Journal:  J Cardiothorac Surg       Date:  2012-06-28       Impact factor: 1.637

6.  Direct vitamin K antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation.

Authors:  Álvaro Hidalgo-Vega; Elham Askari; Rosa Vidal; Isaac Aranda-Reneo; Almudena Gonzalez-Dominguez; Alexandra Ivanova; Gabriela Ene; Pilar Llamas
Journal:  BMC Health Serv Res       Date:  2014-01-30       Impact factor: 2.655

7.  Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position.

Authors:  Gabriela Ene; Aránzazu Garcia Raso; Almudena Gonzalez-Dominguez Weber; Álvaro Hidalgo-Vega; Pilar Llamas
Journal:  SAGE Open Med       Date:  2016-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.